Par Pharmaceutical (PRX) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts PRX Hot Sheet
Price: $49.98 --0%
Financial Fact:
Selling, general and administrative: 54.94M
Today's EPS Names:
CCEL, FNGR, FAST, More
Financial Fact:
Selling, general and administrative: 54.94M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Par Pharmaceutical (NYSE: PRX) reported Q4 EPS of $0.78, $0.03 better than the analyst estimate of $0.75. Revenue for the quarter came in at $253.6 million versus the consensus estimate of $230.31 million.
For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.
For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- Mizuho Reiterates Outperform Rating on Gulfport Energy (GPOR)
- Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
